Exascale Labs Holdings Inc.

Exascale Labs Holdings Inc.

NNASDAQ:XLAB
1.96
USD
-0.18
(-8.41%)
-0.16EPS

Share Statistics

As of March 31, 2026, Exascale Labs Holdings Inc. has 63.20M shares outstanding.

Shares Outstanding63.20M

Financial Position

As of March 31, 2026, Exascale Labs Holdings Inc. maintains a current ratio of 0.28, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities.

Current Ratio0.28
Quick Ratio0.11

Stock Price Statistics

USD

These figures are as of the close on November 16, 2026.

50-Day Moving Average2.36

Income Statement

USD

Over the twelve months ended March 31, 2026, Exascale Labs Holdings Inc. generated 11.70M in revenue and converted that into -9.42M in net income, yielding earnings per share of -0.16. EBITDA reached -3.43M, while operating income came in at -3.44M.

Revenue11.70M
Gross Profit1.78M
Operating Income-3.44M
Pretax Income-9.42M
Net Income-9.42M
EBITDA-3.43M
EBIT-3.44M
Earnings Per Share (EPS)-0.16

Balance Sheet

USD

These figures are as of March 31, 2026. Total book value stands at -20.91M, with working capital of -21.02M providing operational flexibility.

Cash & Cash Equivalents984,830.00
Net Debt-984,830.00
Equity (Book Value)-20.91M
Book Value Per Share-0.33
Working Capital-21.02M

Margins

Over the twelve months ended March 31, 2026, Exascale Labs Holdings Inc. posted a gross margin of 15.19, reflecting its pricing power and cost economics. The operating margin of -29.39 and net profit margin of -80.47 provide insight into operational efficiency.

Gross Margin15.19
Operating Margin-29.39
Pretax Margin-80.47
Profit Margin-80.47
EBITDA Margin-29.35